CH362072A - Verfahren zur Herstellung neuer Acylpiperidine - Google Patents

Verfahren zur Herstellung neuer Acylpiperidine

Info

Publication number
CH362072A
CH362072A CH362072DA CH362072A CH 362072 A CH362072 A CH 362072A CH 362072D A CH362072D A CH 362072DA CH 362072 A CH362072 A CH 362072A
Authority
CH
Switzerland
Prior art keywords
acylpiperidines
new
production
new acylpiperidines
Prior art date
Application number
Other languages
English (en)
Inventor
Karl Dr Hoffmann
Ernst Dr Sury
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of CH362072A publication Critical patent/CH362072A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CH362072D 1957-03-19 1957-03-19 Verfahren zur Herstellung neuer Acylpiperidine CH362072A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH863715X 1957-03-19

Publications (1)

Publication Number Publication Date
CH362072A true CH362072A (de) 1962-05-31

Family

ID=4543410

Family Applications (1)

Application Number Title Priority Date Filing Date
CH362072D CH362072A (de) 1957-03-19 1957-03-19 Verfahren zur Herstellung neuer Acylpiperidine

Country Status (3)

Country Link
CH (1) CH362072A (de)
FR (1) FR1246166A (de)
GB (1) GB863715A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678938A1 (fr) * 1991-07-10 1993-01-15 Rhone Poulenc Rorer Sa Derives de pyrrolidine, leur preparation et les medicaments les contenant.

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123538A (en) * 1977-08-30 1978-10-31 Mcneil Laboratories, Incorporated (2-Amino-2-oxoethoxy)acetic acid compounds, compositions and methods

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678938A1 (fr) * 1991-07-10 1993-01-15 Rhone Poulenc Rorer Sa Derives de pyrrolidine, leur preparation et les medicaments les contenant.
WO1993001167A1 (fr) * 1991-07-10 1993-01-21 Rhone-Poulenc Rorer S.A. Derives de pyrrolidine et thiazolidine, leur preparation et les medicaments les contenant
EP0527069A1 (de) * 1991-07-10 1993-02-10 Aventis Pharma S.A. Pyrrolidin- und Thiazolidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
GB863715A (en) 1961-03-22
FR1246166A (fr) 1960-11-18

Similar Documents

Publication Publication Date Title
CH384747A (de) Verfahren zur Herstellung neuer Farbstoffe
CH375352A (de) Verfahren zur Herstellung neuer 6-Fluor-9a-halogensteroide
CH415632A (de) Verfahren zur Herstellung neuer 3-Pyrrolidylmethylamine
CH373059A (de) Verfahren zur Herstellung neuer Epoxydverbindungen
CH370780A (de) Verfahren zur Herstellung neuer Ferocene
CH367915A (de) Verfahren zur Herstellung neuer Farbstoffe
CH387033A (de) Verfahren zur Herstellung neuer Halogenpregnene
CH362072A (de) Verfahren zur Herstellung neuer Acylpiperidine
CH375351A (de) Verfahren zur Herstellung neuer 6,21-Difluor-9a-halogen-steroide
CH407970A (de) Verfahren zur Herstellung neuer Telomerisate
CH396872A (de) Verfahren zur Herstellung neuer Harnstoffe
CH346956A (de) Verfahren zur Herstellung neuer 1,4-Dioxy-5-acylaminoanthrachinone
CH366283A (de) Verfahren zur Herstellung neuer Dioxotetrahydropyridazine
CH366532A (de) Verfahren zur Herstellung neuer Aminosteroidverbindungen
CH371795A (de) Verfahren zur Herstellung neuer 11,18-Oxido-steroide
CH383372A (de) Verfahren zur Herstellung neuer 2-Fluorsteroide
CH367824A (de) Verfahren zur Herstellung neuer Halogenandrostene
AT206443B (de) Verfahren zur Herstellung neuer tetrahydro-dioxopyridazine
CH356464A (de) Verfahren zur Herstellung neuer Tetrahydrodioxopyridazine
CH407072A (de) Verfahren zur Herstellung neuer Telomerisate
AT217475B (de) Verfahren zur Herstellung neuer Äthylen-bis-dithiocarbamat-Manganverbindungen
CH375729A (de) Verfahren zur Herstellung von Rhodaniden
CH460752A (de) Verfahren zur Herstellung neuer 9B,10a-Bisnorchol-22-aldehyde
AT193363B (de) Verfahren zur Herstellung neuer Trihalogenäthylenverbindungen
AT234917B (de) Verfahren zur Herstellung neuer Halogenpregnene